Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2025

Jan 23, 2025

34491_dirs_2025-01-22_afe723f3-558a-458d-a98e-71935f3f0d4f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2025-01-20

Reporting Person: Kelly John Alexander (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-01-20 Common Stock M 44368 Acquired 84554 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-01-20 Restricted Stock Units $ M 3889 Disposed Common Stock (3889) Direct
2025-01-20 Restricted Stock Units $ M 13904 Disposed Common Stock (13904) Direct
2025-01-20 Restricted Stock Units $ M 26575 Disposed Common Stock (26575) Direct

Footnotes

F1: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2025.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4: On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F5: On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.